COVID-19 and Liquid Homeostasis in the Lung-A Perspective through the Epithelial Sodium Channel (ENaC) Lens.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
31 05 2022
Historique:
received: 03 05 2022
revised: 23 05 2022
accepted: 25 05 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

Infections with a new corona virus in 2019 lead to the definition of a new disease known as Corona Virus Disease 2019 (COVID-19). The sever cases of COVID-19 and the main cause of death due to virus infection are attributed to respiratory distress. This is associated with the formation of pulmonary oedema that impairs blood oxygenation and hypoxemia as main symptoms of respiratory distress. An important player for the maintenance of a defined liquid environment in lungs needed for normal lung function is the epithelial sodium channel (ENaC). The present article reviews the implications of SARS-CoV-2 infections from the perspective of impaired function of ENaC. The rationale for this perspective is derived from the recognition that viral spike protein and ENaC share a common proteolytic cleavage site. This cleavage site is utilized by the protease furin, that is essential for ENaC activity. Furin cleavage of spike 'activates' the virus protein to enable binding to host cell membrane receptors and initiate cell infection. Based on the importance of proteolytic cleavage for ENaC function and activation of spike, it seems feasible to assume that virus infections are associated with impaired ENaC activity. This is further supported by symptoms of COVID-19 that are reminiscent of impaired ENaC function in the respiratory tract.

Identifiants

pubmed: 35681496
pii: cells11111801
doi: 10.3390/cells11111801
pmc: PMC9180030
pii:
doi:

Substances chimiques

Epithelial Sodium Channels 0
Viral Proteins 0
Peptide Hydrolases EC 3.4.-
Furin EC 3.4.21.75

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149
pubmed: 32747721
Physiol Rev. 2020 Jul 1;100(3):1065-1075
pubmed: 32216698
ESC Heart Fail. 2021 Feb;8(1):171-174
pubmed: 33205539
Annu Rev Physiol. 1999;61:627-61
pubmed: 10099704
Chem Senses. 2020 May 21;45(4):235-248
pubmed: 32006019
Annu Rev Physiol. 2009;71:361-79
pubmed: 18928407
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Am J Respir Cell Mol Biol. 2007 Jan;36(1):1-7
pubmed: 16888286
J Cyst Fibros. 2008 May;7(3):197-205
pubmed: 17766193
Lung. 2004;182(5):297-317
pubmed: 15742242
Am J Physiol Lung Cell Mol Physiol. 2012 Dec 15;303(12):L1013-26
pubmed: 22983350
J Biol Chem. 2004 Apr 30;279(18):18111-4
pubmed: 15007080
Circulation. 2020 Jul 14;142(2):101-104
pubmed: 32369390
J Physiol. 2010 Apr 15;588(Pt 8):1211-25
pubmed: 20194130
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1322-31
pubmed: 10764330
N Engl J Med. 1999 Jul 15;341(3):156-62
pubmed: 10403853
Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):247-51
pubmed: 8278374
J Biol Chem. 2007 Mar 2;282(9):6153-60
pubmed: 17199078
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10282-7
pubmed: 10920189
Am J Physiol Cell Physiol. 2020 Jan 1;318(1):C150-C162
pubmed: 31721612
Physiol Rev. 2005 Jul;85(3):811-44
pubmed: 15987796
Proc Am Thorac Soc. 2004;1(1):42-6
pubmed: 16113411
Am J Physiol Renal Physiol. 2012 Jan 1;302(1):F1-8
pubmed: 21993886
Pflugers Arch. 2022 Feb;474(2):177-179
pubmed: 34799769
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Comp Biochem Physiol A Mol Integr Physiol. 2021 Mar;253:110869
pubmed: 33326845
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8418-22
pubmed: 7667305
Nature. 2010 Mar 11;464(7286):297-301
pubmed: 20107438
Function (Oxf). 2020;1(2):zqaa024
pubmed: 33201937
Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L366-73
pubmed: 15121635
Gene. 2016 Apr 1;579(2):95-132
pubmed: 26772908
Nat Genet. 1996 Mar;12(3):325-8
pubmed: 8589728
EMBO Mol Med. 2010 Jan;2(1):26-37
pubmed: 20043279
Science. 1991 Dec 20;254(5039):1797-9
pubmed: 1722350
Hum Mutat. 2009 Jul;30(7):1093-103
pubmed: 19462466
Am J Respir Cell Mol Biol. 2006 Jul;35(1):10-9
pubmed: 16514116
Int J Mol Sci. 2021 May 09;22(9):
pubmed: 34065111
J Biomed Biotechnol. 2011;2011:174306
pubmed: 22131798
J Biol Chem. 2003 Sep 26;278(39):37073-82
pubmed: 12871941
J Virol. 2011 May;85(9):4122-34
pubmed: 21325420
J Pediatr. 1999 Dec;135(6):739-45
pubmed: 10586178
Neuron. 2020 Jun 3;106(5):816-829.e6
pubmed: 32229307
Am J Physiol Lung Cell Mol Physiol. 2000 Jul;279(1):L14-24
pubmed: 10893198
Am J Physiol. 1995 Aug;269(2 Pt 1):C511-8
pubmed: 7653534
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
J Biol Chem. 2009 Jul 31;284(31):20447-51
pubmed: 19401469
Crit Care. 2021 Jun 1;25(1):186
pubmed: 34074313
J Appl Physiol (1985). 1995 Nov;79(5):1615-28
pubmed: 8594022
PLoS One. 2015 Aug 26;10(8):e0135224
pubmed: 26309024
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Nat Immunol. 2015 Jan;16(1):27-35
pubmed: 25521682
Am J Physiol. 1998 Aug;275(2):L414-22
pubmed: 9700104
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
FASEB J. 2009 Nov;23(11):3829-42
pubmed: 19596899
Nature. 1993 Feb 4;361(6411):467-70
pubmed: 8381523
Elife. 2020 May 26;9:
pubmed: 32452762
Am J Physiol Lung Cell Mol Physiol. 2001 Jul;281(1):L16-23
pubmed: 11404240
J Biol Chem. 2002 Mar 8;277(10):8338-45
pubmed: 11756432
Curr Opin Pulm Med. 2011 Nov;17(6):478-83
pubmed: 21857224
Am J Physiol Lung Cell Mol Physiol. 2009 Mar;296(3):L372-83
pubmed: 19112100
Am J Physiol Cell Physiol. 2004 Jan;286(1):C190-4
pubmed: 12967915
Nat Rev Dis Primers. 2019 Mar 14;5(1):18
pubmed: 30872586
Elife. 2018 Sep 25;7:
pubmed: 30251954
Nature. 1991 Dec 19-26;354(6354):526-8
pubmed: 1722027
Annu Rev Physiol. 2005;67:471-90
pubmed: 15709966
Pulm Med. 2011;2011:830320
pubmed: 21637371
Nat Rev Mol Cell Biol. 2022 Jan;23(1):3-20
pubmed: 34611326
Nature. 1994 Feb 3;367(6462):463-7
pubmed: 8107805
Nature. 1997 Oct 9;389(6651):607-10
pubmed: 9335501
Nat Med. 2004 May;10(5):487-93
pubmed: 15077107
Compr Physiol. 2013 Apr;3(2):849-915
pubmed: 23720333
Front Physiol. 2012 May 22;3:146
pubmed: 22661953
Annu Rev Cell Dev Biol. 2011;27:213-35
pubmed: 21721945
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Acta Physiol (Oxf). 2022 May;235(1):e13811
pubmed: 35276025
J Biol Chem. 2004 Nov 19;279(47):48491-4
pubmed: 15466477
J Biol Chem. 1995 Nov 17;270(46):27411-4
pubmed: 7499195
J Proteome Res. 2020 Nov 6;19(11):4316-4326
pubmed: 33090793

Auteurs

Emily F Brown (EF)

Department of Physiology, University of Otago, Dunedin 9054, New Zealand.
HeartOtago, University of Otago, Dunedin, New Zealand.

Tamapuretu Mitaera (T)

Department of Physiology, University of Otago, Dunedin 9054, New Zealand.
HeartOtago, University of Otago, Dunedin, New Zealand.

Martin Fronius (M)

Department of Physiology, University of Otago, Dunedin 9054, New Zealand.
HeartOtago, University of Otago, Dunedin, New Zealand.
Healthy Hearts for Aotearoa New Zealand, Centre of Research Excellence, New Zealand.
Maurice Wilkins Centre for Molecular Discovery, Centre of Research Excellence, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH